Cancer Prevention with Molecular Target Therapies / / edited by Laura Paleari.
Personalized medicine plays an important role in cancer prevention. To date, it is clear that many cancers are molecularly distinct subtypes, and different therapeutic approaches would be required for each. Indeed, the identification of cancer susceptibility genes permits identifying patients "...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, [2023] |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (208 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993610555004498 |
---|---|
ctrlnum |
(CKB)5470000002907797 (NjHacI)995470000002907797 (EXLCZ)995470000002907797 |
collection |
bib_alma |
record_format |
marc |
spelling |
Cancer Prevention with Molecular Target Therapies / edited by Laura Paleari. Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, [2023] 1 online resource (208 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Personalized medicine plays an important role in cancer prevention. To date, it is clear that many cancers are molecularly distinct subtypes, and different therapeutic approaches would be required for each. Indeed, the identification of cancer susceptibility genes permits identifying patients "at risk" of developing neoplasia and supports modifying individual risk behaviors or the choice of preventive therapy. Additionally, the efficacy of various targeted therapies in different cancer subtypes suggests that treatment choices in the near future will be more and more centered on molecular signatures. Data from preclinical, clinical, and observational studies have revealed the ability to prevent cancer development for compounds with different indications than cancer. The concept of drug repurposing permits combinations that can target several critical pathways of a specific disease, decreasing the risk of resistance observed when using single-agent targeted therapy. This open-access Special Issue brings together original research and review articles on molecular oncology with attention to the early detection and prevention of cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this Special Issue is to provide an open-source sharing of significant works in the field of molecular oncology that can increase our understanding of cancer development, which may lead to the discovery of new molecular diagnostic technologies and targeted therapeutics. Cancer Treatment. 3-0365-7926-5 Paleari, Laura, editor. |
language |
English |
format |
eBook |
author2 |
Paleari, Laura, |
author_facet |
Paleari, Laura, |
author2_variant |
l p lp |
author2_role |
TeilnehmendeR |
title |
Cancer Prevention with Molecular Target Therapies / |
spellingShingle |
Cancer Prevention with Molecular Target Therapies / |
title_full |
Cancer Prevention with Molecular Target Therapies / edited by Laura Paleari. |
title_fullStr |
Cancer Prevention with Molecular Target Therapies / edited by Laura Paleari. |
title_full_unstemmed |
Cancer Prevention with Molecular Target Therapies / edited by Laura Paleari. |
title_auth |
Cancer Prevention with Molecular Target Therapies / |
title_new |
Cancer Prevention with Molecular Target Therapies / |
title_sort |
cancer prevention with molecular target therapies / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2023 |
physical |
1 online resource (208 pages) |
isbn |
3-0365-7926-5 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC270 |
callnumber-sort |
RC 3270.8 C363 42023 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.99406 |
dewey-sort |
3616.99406 |
dewey-raw |
616.99406 |
dewey-search |
616.99406 |
work_keys_str_mv |
AT palearilaura cancerpreventionwithmoleculartargettherapies |
status_str |
n |
ids_txt_mv |
(CKB)5470000002907797 (NjHacI)995470000002907797 (EXLCZ)995470000002907797 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Cancer Prevention with Molecular Target Therapies / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653284212080640 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02515nam a2200289 i 4500</leader><controlfield tag="001">993610555004498</controlfield><controlfield tag="005">20230816201417.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230816s2023 sz o 000 0 eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/books978-3-0365-7926-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5470000002907797</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995470000002907797</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995470000002907797</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC270.8</subfield><subfield code="b">.C363 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99406</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Cancer Prevention with Molecular Target Therapies /</subfield><subfield code="c">edited by Laura Paleari.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">[2023]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (208 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Personalized medicine plays an important role in cancer prevention. To date, it is clear that many cancers are molecularly distinct subtypes, and different therapeutic approaches would be required for each. Indeed, the identification of cancer susceptibility genes permits identifying patients "at risk" of developing neoplasia and supports modifying individual risk behaviors or the choice of preventive therapy. Additionally, the efficacy of various targeted therapies in different cancer subtypes suggests that treatment choices in the near future will be more and more centered on molecular signatures. Data from preclinical, clinical, and observational studies have revealed the ability to prevent cancer development for compounds with different indications than cancer. The concept of drug repurposing permits combinations that can target several critical pathways of a specific disease, decreasing the risk of resistance observed when using single-agent targeted therapy. This open-access Special Issue brings together original research and review articles on molecular oncology with attention to the early detection and prevention of cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this Special Issue is to provide an open-source sharing of significant works in the field of molecular oncology that can increase our understanding of cancer development, which may lead to the discovery of new molecular diagnostic technologies and targeted therapeutics.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-7926-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paleari, Laura,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-18 03:31:46 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-07-04 13:45:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5346845470004498&Force_direct=true</subfield><subfield code="Z">5346845470004498</subfield><subfield code="b">Available</subfield><subfield code="8">5346845470004498</subfield></datafield></record></collection> |